PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 43 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

9 April 2025

  1. (diff | hist) 08:41 Talk:Wuhan Wansheng Biotechnology 822 +236 TallySheetTad (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  2. (diff | hist) m b 07:28 Liraglutide 5,250 +718 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  3. (diff | hist) 07:07 Multi-dose vial 11,251 +853 LeanMassLars (talk | contribs) expand §Reconstituted peptides and multiple withdrawal [rollback]

8 April 2025

  1. (diff | hist) m 23:46 Dose escalation schedule 4,073 +423 CarryOverCai (talk | contribs) state the number of doses a vial yields at that concentration [rollback]
  2. (diff | hist) 21:27 Insulin syringe unit conversion 4,444 +780 ReceptorRhoda (talk | contribs) add the note that vial overfill is not assumed [rollback]
  3. (diff | hist) m 21:20 Survodutide 4,470 ±0 SemaglutideSasha (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  4. (diff | hist) 21:13 Arcuate nucleus 4,321 ±0 RetatrutideRuben (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  5. (diff | hist) 20:46 Karl Fischer titration 7,209 +164 AnalyticalAnnie (talk | contribs) expand §Relationship to other methods [rollback]
  6. (diff | hist) 14:03 Talk:Cold chain 748 +362 ColdChainCleo (talk | contribs) /* Mean kinetic temperature: the worked example */ reply
  7. (diff | hist) 14:02 Talk:Wuhan Wansheng Biotechnology 611 +338 AnalyticalAnnie (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  8. (diff | hist) 11:19 Talk:Cold chain 537 +235 PlainNumbersPip (talk | contribs) /* Mean kinetic temperature: the worked example */ new section
  9. (diff | hist) 09:15 Talk:Wuhan Wansheng Biotechnology 400 +414 RfC_Rasmus (talk | contribs) /* RfC: what does a large report set actually support? */ new section
  10. (diff | hist) N 09:00 Hubei Jianxiang Bioscience 1,717 +1,717 SortKeySascha (talk | contribs) create organisation article per PP:VN
  11. (diff | hist) 06:49 Guangzhou JEEP Biotechnology 11,377 +1,381 StudentSindhu (talk | contribs) add the reception tally with its period and count stated [rollback]
  12. (diff | hist) 00:34 Test report forgery 4,203 +65 PioneerPerdita (talk | contribs) unpipe a link that did not need piping [rollback]

7 April 2025

  1. (diff | hist) 11:03 STEP trial programme 4,357 ±0 PreregPriya (talk | contribs) add the year of publication to each trial in the list [rollback]
  2. (diff | hist) 10:14 Vial filling and stoppering 4,012 +256 SPPS_Sorrel (talk | contribs) expand §Stoppering and seal integrity [rollback]
  3. (diff | hist) 09:57 Electrospray ionisation 3,512 +34 Peptide_Pete (talk | contribs) state the titration endpoint and the reagent factor [rollback]
  4. (diff | hist) 09:38 Prescribing information 3,683 ±0 LurkerLevi (talk | contribs) add the note that price is not a proxy for quality [rollback]
  5. (diff | hist) m 07:42 Proglucagon 5,743 +18 IpamorelinIsold (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  6. (diff | hist) m b 03:10 Reverse-phase HPLC 4,282 +36 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  7. (diff | hist) m 02:43 Peptide stability table 4,018 +104 SurmountSurma (talk | contribs) expand §The table [rollback]

6 April 2025

  1. (diff | hist) m 22:17 Wuhan Wansheng Biotechnology 10,241 ±0 ChainCustodyChad (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  2. (diff | hist) m 19:20 Gastric emptying 4,636 ±0 Chromatokid (talk | contribs) add the reference range with the assay it was established on [rollback]
  3. (diff | hist) 18:22 Hypoglycaemia 3,743 ±0 RetinopathyRex (talk | contribs) give the incidence with its denominator [rollback]
  4. (diff | hist) 17:16 Insulin secretion 5,442 ±0 ProglucagonPia (talk | contribs) alphabetise the see-also list [rollback]
  5. (diff | hist) 15:23 Bachem Holding (Suzhou) 9,738 +751 BlindSampleBrid (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  6. (diff | hist) m b 10:33 Nantong Guangyuan Chemical 9,606 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 08:57 Retatrutide 5,870 +170 ApoB_Aurelio (talk | contribs) add see also to the amylin analogue [rollback]
  8. (diff | hist) 06:41 Bacteriostatic water 4,348 +524 SupplyWatchSuri (talk | contribs) give the concentration in mg/mL as well as in units [rollback]
  9. (diff | hist) m 05:13 Medutest 3,795 ±0 NPOV_Nadia (talk | contribs) split §What a report shows from §What it does not [rollback]
  10. (diff | hist) 03:34 Peptide harm reduction 3,438 +118 ParentCatPansy (talk | contribs) fix a broken wikilink [rollback]
  11. (diff | hist) m 01:19 Timeline of incretin therapeutics 3,954 +803 DiffWatchDov (talk | contribs) add the molecular formula to the infobox [rollback]

5 April 2025

  1. (diff | hist) m 18:01 Fasting insulin 3,216 +254 GsCouplingGil (talk | contribs) add category for laboratory medicine [rollback]
  2. (diff | hist) 15:30 Melanotan II 3,650 +259 ThymosinTamsin (talk | contribs) give the counterion, since it changes the mass by several per cent [rollback]
  3. (diff | hist) 14:26 Trial data comparison 4,023 +806 INN_Ingrid (talk | contribs) add the citation for the stability figures taken from the labelling [rollback]
  4. (diff | hist) m 13:53 Custom peptide synthesis 3,777 ±0 ColdChainCleo (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  5. (diff | hist) 11:57 Cold chain 20,418 +196 CounterfeitCato (talk | contribs) state that overlay gas is used and name it [rollback]
  6. (diff | hist) 11:48 Reference standard 4,154 +34 ChromCleanupCass (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) 08:29 ChinaPeptides 7,361 +80 API_Aurora (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 06:55 Aspiration risk under anaesthesia 3,880 ±0 MolarMassMaeve (talk | contribs) add the discontinuation rate attributable to this effect [rollback]
  9. (diff | hist) 02:16 Cost per milligram 3,001 +854 TirzTaxonomist (talk | contribs) correct the deductible description [rollback]
  10. (diff | hist) 00:28 Preparative HPLC purification 3,866 ±0 DiffWatchDov (talk | contribs) British spelling per PP:MOS [rollback]

4 April 2025

  1. (diff | hist) m 21:04 Peptide content 6,898 +351 LeanMassLars (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  2. (diff | hist) m 20:29 Repackaging 3,958 ±0 Chromatokid (talk | contribs) add the collapse-temperature point, sourced [rollback]
  3. (diff | hist) 12:32 Placebo-adjusted effect 3,893 +222 AxisLabelAgda (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  4. (diff | hist) 09:31 Talk:Shanghai Wibson Biotechnology 959 +180 StyleSheetSybil (talk | contribs) /* A shorter registry history is not a finding */ reply
  5. (diff | hist) m 08:56 Active pharmaceutical ingredient 3,553 +118 MicrodoseMagnus (talk | contribs) correct the description of the research-use-only exemption [rollback]
  6. (diff | hist) m 07:48 Lyophilisation 20,027 +147 TrialsTabitha (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  7. (diff | hist) 04:49 Crude peptide 3,916 ±0 PancreasPru (talk | contribs) ce per PP:MOS [rollback]

3 April 2025

  1. (diff | hist) 21:52 Xi'an Mokemei Biotechnology 2,368 ±0 COA_Colwyn (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 20:14 Area percent purity 6,569 ±0 StabilityStig (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 14:07 Talk:Shanghai Wibson Biotechnology 748 +179 AnalyticalAnnie (talk | contribs) /* A shorter registry history is not a finding */ reply
  4. (diff | hist) 12:20 Counterfeit peptide 3,976 +98 ForgeryFinder (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  5. (diff | hist) 10:22 Talk:Shanghai Wibson Biotechnology 537 +213 UnderfillUna (talk | contribs) /* A shorter registry history is not a finding */ new section
  6. (diff | hist) 08:00 Flourishglobal Peptide Biotech 4,675 +1,087 MarginNoteMars (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  7. (diff | hist) 03:21 Albumin binding half-life extension 4,872 ±0 EmptyingElke (talk | contribs) ce per PP:MOS [rollback]

2 April 2025

  1. (diff | hist) 19:16 Oral semaglutide 3,542 +23 ExenatideEzra (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  2. (diff | hist) m 08:59 SELECT trial 4,206 ±0 TrialsTabitha (talk | contribs) add the DOI [rollback]
  3. (diff | hist) 08:57 Talk:Multi-dose vial 1,170 +250 StopperingSteff (talk | contribs) /* Merge proposal from Vial — response */ reply
  4. (diff | hist) 05:38 Global access disparity 2,619 ±0 Chromatokid (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  5. (diff | hist) 00:48 Third-party testing 5,770 ±0 BetaCellBoyd (talk | contribs) typo [rollback]

1 April 2025

  1. (diff | hist) 21:35 Insulin syringe 4,111 ±0 DiluentDiya (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  2. (diff | hist) m 21:16 Haemoglobin A1c 3,366 ±0 B12_Bettina (talk | contribs) state which fraction the assay actually measures [rollback]
  3. (diff | hist) m 18:28 LEADER trial 3,537 ±0 UnitsUrsula (talk | contribs) split the results table so the two doses are separate rows [rollback]
  4. (diff | hist) 14:33 International nonproprietary name 3,145 ±0 Chromatokid (talk | contribs) split overlong sentence [rollback]
  5. (diff | hist) 13:48 Good manufacturing practice 3,919 +371 IsocraticIla (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  6. (diff | hist) m 12:55 GLP-1 receptor 6,418 +313 TirzTaxonomist (talk | contribs) expand §Distribution and its clinical consequences [rollback]
  7. (diff | hist) m b 09:59 Weight regain after discontinuation 4,031 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  8. (diff | hist) m 06:17 Receptor bias 3,536 +19 EmptyingElke (talk | contribs) expand §The concept [rollback]
  9. (diff | hist) 04:08 Chinese Peptide Company 10,500 +526 AnalyticalAnnie (talk | contribs) add the reception tally with its period and count stated [rollback]
  10. (diff | hist) m 00:53 Peptide synthesis 4,113 ±0 TechnicianTeal (talk | contribs) fix the anchor on an internal link [rollback]

31 March 2025

  1. (diff | hist) m b 20:38 Tianjin Finder Chemical 6,856 +249 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  2. (diff | hist) m b 20:32 Beyond-use date 13,114 +1,020 CategoryBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 16:33 Reconstitution of lyophilised peptides 4,389 ±0 HyphenHarriet (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  4. (diff | hist) 15:51 Batch number 3,708 ±0 LotTraceLuka (talk | contribs) expand §Assignment [rollback]
  5. (diff | hist) 10:58 Contraindications of incretin therapy 4,296 +726 HypoHildur (talk | contribs) add the perioperative consideration with the society guidance it comes from [rollback]
  6. (diff | hist) 09:43 Amylin 4,252 ±0 Retention_Time_Rae (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) m 00:52 Solid-phase peptide synthesis 5,076 ±0 API_Aurora (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]

30 March 2025

  1. (diff | hist) 20:52 Exenatide 4,288 ±0 CagriCass (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 18:44 SURMOUNT trial programme 3,559 ±0 GastroparesisGwen (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  3. (diff | hist) 15:14 MOTS-c 3,248 +552 EpitalonEoin (talk | contribs) split the pharmacology section from the marketing history [rollback]
  4. (diff | hist) 12:11 GL Biochem (Shanghai) 12,955 +1,223 LotTraceLuka (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  5. (diff | hist) 11:28 Patent expiry and biosimilars 3,211 +38 BiliaryBea (talk | contribs) add the effective date to the regulatory table [rollback]
  6. (diff | hist) m 09:24 Mass spectrometry 5,223 ±0 NewLabNell (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  7. (diff | hist) m 07:38 Triple agonist 3,428 ±0 CuriousCallum (talk | contribs) copyedit [rollback]
  8. (diff | hist) 06:46 Customs seizure 3,147 +133 API_Aurora (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]
  9. (diff | hist) m 06:02 Research use only 6,689 ±0 LiraLotte (talk | contribs) expand §Legal position and importation [rollback]
  10. (diff | hist) m 02:22 Vial 18,279 +550 StopperingSteff (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  11. (diff | hist) m 01:54 Baseline laboratory panel 3,039 ±0 Chromatokid (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  12. (diff | hist) m 00:28 Shanghai Sigma-Audley New Material Technology 7,517 ±0 ForgeryFinder (talk | contribs) sentence case in headings per PP:MOS [rollback]

29 March 2025

  1. (diff | hist) m b 23:00 USP General Chapter 71 3,363 +271 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) 21:57 Sarcopenia 3,440 +121 SecondarySrc_Seb (talk | contribs) state the fasting requirement explicitly [rollback]
  3. (diff | hist) 19:50 Analytical method validation 4,442 ±0 Areapercent_Ayo (talk | contribs) fix indentation in the source [rollback]
  4. (diff | hist) 18:13 Chain of custody 4,085 ±0 SemaxSevi (talk | contribs) add the cross-link to the traceability article [rollback]
  5. (diff | hist) m 15:09 Drug master file 3,180 ±0 FiveOhThreeB (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  6. (diff | hist) m 11:11 Bacterial endotoxin test 4,398 ±0 PreregPriya (talk | contribs) British spelling per PP:MOS [rollback]
  7. (diff | hist) m 09:39 Contract development and manufacturing organisation 3,804 +220 RepackRadek (talk | contribs) alphabetise the see-also list [rollback]
  8. (diff | hist) 08:44 Talk:Multi-dose vial 1,033 +86 BUD_Bertram (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  9. (diff | hist) 06:36 Amylin receptor agonist 3,909 ±0 CuriousCallum (talk | contribs) ce [rollback]